Dr. Rooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287Phone+1 410-955-5000Fax+1 410-955-5001
Education & Training
- Johns Hopkins University School of MedicineSurgical Pathology, 2016 - 2017
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2016
- University of Illinois College of MedicineClass of 2012, MD, With Honors
- Northwestern UniversityBS, Communication, Summa Cum Laude, 2001 - 2005
Certifications & Licensure
- DC State Medical License 2023 - 2027
- MD State Medical License 2015 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell Carci...Stephanie A Hart, Jen-Fan Hang, Rebecca D Chernock, Michael W Mikula, Lisa Rooper
The American Journal of Surgical Pathology. 2025-02-01 - Cholangioblastic Cholangiocarcinoma (NIPBL::NACC1 cholangiocarcinoma): Expanded Morphologic Spectrum and Further Genetic Characterization.Pedram Argani, Kiyoko Oshima, Robert A Anders, Raul S Gonzalez, Osman Yilmaz
The American Journal of Surgical Pathology. 2025-01-16 - The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K-AKT pathway.Xiaopei Shen, Jie Tan, Rengyun Liu, Guangwu Zhu, Lisa Rooper
Molecular Oncology. 2025-01-01
Journal Articles
- Exceptional Responses to Pertuzumab, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor‐2 High Expressing Salivary Duct CarcinomasLisa Rooper, Robert D Foss, Hyunseok Kang, Rishi Sawhney, Nicole C Schmitt, Head & Neck
- Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient CarcinomaJosh Lauring, Lisa Rooper, Sarah Sagorsky, Hyunseok Kang, The Oncologist
Professional Memberships
- Junior Member
- Junior Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: